In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Sanofi, with a price target of €105.00. The company’s shares closed yesterday at $95.03.Elevate Your Investing...
Sanofi ((SNYNF)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and...
Sanofi ((SNYNF)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and...
Sanofi ((SNYNF)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Merus (MRUS – Research Report), Exelixis (EXEL – Research Report) and Sanofi (SNYNF – Research Report).Elevate Your...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cytokinetics (CYTK – Research Report) and Sanofi (SNYNF – Research Report) with bullish sentiments.Elevate...
UBS analyst Matthew Weston maintained a Buy rating on Sanofi today and set a price target of €105.00. The company’s shares closed last Wednesday at $99.00.Elevate Your Investing Strategy: Take advantage...
Sanofi ((SNYNF)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and...
Sanofi ((SNYNF)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and...
Sanofi ((SNYNF)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and...